Skip to main content

Benitec, Biomics Finalize Expressed RNAi Rx Collaboration for HBV

Premium

Australia’s Benitec said this week that it has entered into binding agreements with Chinese drug firm Biomics Biotechnologies to develop an expressed RNAi-based treatment for chronic hepatitis B infection.

In July, Benitec first announced that it had agreed to work with Biomics on the therapy (see RNAi News, 7/16/2009). Now, the companies have “put together the final project plan, budgets, and agreements” for the HBV effort, Benitec CEO Sue MacLeman said in a statement.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.